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Abstract
Introduction: Radiographic descriptions of gout have noted the tendency to hypertrophic bone changes. The aim
of this study was to characterize the features of new bone formation (NBF) in gout, and to determine the
relationship between NBF and other radiographic features of disease, particularly erosion and tophus.
Methods: Paired plain radiographs (XR) and computed tomography (CT) scans of 798 individual hand and wrist
joints from 20 patients with gout were analyzed. Following a structured review of a separate set of images, films
were scored for the presence of the following features of NBF: spur, osteophyte, periosteal NBF, ankylosis and
sclerosis. The relationship between NBF and other radiographic features was analyzed.
Results: The most frequent forms of NBF were bone sclerosis and osteophyte. Spur and periosteal NBF were less
common, and ankylosis was rare. On both XR and CT, joints with bone erosion were more likely to have NBF; for
CT, if erosion was present, the odds ratios (OR) was 45.1 for spur, 3.3 for osteophyte, 16.6 for periosteal NBF, 26.6
for ankylosis and 32.3 for sclerosis, P for all < 0.01. Similarly, on CT, joints with intraosseous tophus were more likely
to have NBF; if tophus was present, the OR was 48.4 for spur, 3.3 for osteophyte, 14.5 for periosteal NBF, 35.1 for
ankylosis and 39.1 for sclerosis; P for all < 0.001.
Conclusions: This detailed quantitative analysis has demonstrated that NBF occurs more frequently in joints
affected by other features of gout. This work suggests a connection between bone loss, tophus, and formation of
new bone during the process of joint remodelling in gout.
Introduction
Classical radiological descriptions of gout highlight a
number of characteristic features [1-4]. These include
soft tissue masses representing tophi, and intra- and
extra-articular erosions. In addition, descriptions have
noted the tendency to hypertrophic bone changes [1-4].
Although these changes have been documented in the
literature, the patterns of new bone formation (NBF) in
gout have not been well characterized. Furthermore, the
relationship between NBF and other radiographic fea-
tures such as tophi and erosion is also unknown. Char-
acterization of these changes may provide new insights
into the mechanisms of bone remodelling in joints
affected by gout.
Computed tomography (CT) provides excellent visua-
lization and characterization of bone morphology, and
also allows reliable assessment of tophus detection and
size [5-7]. Through systematic analysis of bone changes
and tophi, CT has the potential to provide new under-
standing of the mechanisms of bone remodelling in
gout. The aim of this study was to define the features of
NBF in joints affected by gout, and to determine the
relationship between NBF and other radiographic fea-
tures of disease, particularly bone erosion and tophus.
Materials and methods
Identification and definitions of new bone formation
features
Following a review of patterns and scoring systems of
NBF in other arthropathies [8-12], plain radiographs
and CT scans from patients with tophaceous gout were
reviewed by two rheumatologists with expertise in gout
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imaging (ND and FMcQ) and a musculoskeletal radiolo-
gist (AD). The review included a structured analysis of
the images and identification of NBF features for assess-
ment and measurement in the systematic site-by-site
analysis. Images of the hands and the feet were used in
this identification process. Definitions for all scored
NBF features were agreed. A reference image library was
constructed for use during the scoring process. The fol-
lowing NBF features were identified (with definitions):
spur (a sharp spicule of dense bone proliferation extend-
ing at an acute angle from the cortex), osteophyte (bone
projection arising along the joint margin and associated
with cartilage [13]), periosteal NBF (bone proliferation
arising from the periosteum), ankylosis (fusion of the
bones of a joint, with trabeculae crossing the joint
space), and sclerosis (increased density of medullary or
subcortical bone). Examples of each NBF feature on
plain radiography and CT are shown in Figure 1. Prior
to formal scoring, both scorers (ND and AM) undertook
a training calibration exercise which involved scoring
five further sets of plain radiographs and CT scans.
Site-by-site quantitative analysis of new bone formation
The site-by site analysis of NBF was completed using
plain radiographs and CT scans of the hands in a
further 20 patients with gout. These images were not
used in the initial identification and calibration exercises
described above. This dataset was selected because the
clinical and radiographic features have been character-
ized in detail previously [6,7,14]. All patients were
recruited from rheumatology clinics and had a history
of acute gout according to Wallace criteria [15]. Plain
radiographs and conventional CT scans of the hands
were obtained for all patients. On the day of the scans,
patients had a clinical assessment including gout history
and laboratory testing.
Plain radiographs of the hands were obtained using a
Toshiba KXO-50F X-ray machine on single-emulsion
film. A standard two view examination (anteroposterior
and ball-catchers views) was obtained (60 kV, 3.2 mAs).
A 102 cm focal film distance with the smallest possible
focal spot was used. The X-ray was centered between
the second and third metacarpophalangeal (MCP) joints,
perpendicular to the plane of the film. Plain radiographs
were scored for erosion (0-5) and joint space narrowing
(JSN) (0-4), according to the Sharp-van der Heijde (S-
vdH) rheumatoid arthritis method, modified for gout
[16]. This method scores erosion in the hands at the
distal interphalangeal (DIP) joints, proximal interphalan-
geal (PIP) joints, interphalangeal (IP) joint of the thumb,
MCP joints, base of the first metacarpal, multangular,
scaphoid, lunate, radius and ulna.
The CT scans of the hands were performed on a Phi-
lips Brilliance 16-slice scanner (Philips Medical Systems,
Best, The Netherlands), as previously described [6]. All
scans were performed with the same image protocol;
acquisition at 16 × 0.75 mm, reconstructed on a bone
algorithm, 768 matrix, to 0.8 mm slices with a 0.4 mm
increment (kVp 140, 120 mAs/slice). Additional recon-
structions were done on a soft tissue algorithm, 512
matrix, also to a 0.8 mm slice with a 0.4 mm increment.
The images were viewed as 0.8 mm slices on a Philips
CT workstation and reconstructed to 3 mm slices for
viewing on Picture Archiving Communication System
(PACS). CT scans were assessed for the presence and
diameter of intraosseous tophi and similarly for ero-
sions, as previously reported [7].
The erosion and tophus scoring was undertaken more
than three years before the NBF scoring. The scorers of
NBF were blinded to the clinical and imaging results
(including the erosion, JSN and intraosseous tophus
scores). All clinical, laboratory and imaging assessments
were approved by the local ethics committee, and
patients provided written informed consent.
Scoring of new bone formation
Plain radiographs and CT scans of the hands were
scored for features of NBF by a rheumatologist with
experience in gout imaging (ND) and a musculoskeletal
radiologist (AM). Plain radiographs and CT scans were
scored separately. Plain radiographs were scored first,
and the scores for the plain radiographs were not avail-
able for review by the scorer at the time of the CT scor-
ing. Sites for NBF scoring were those included in the
gout-modified S-vdH method for erosion scoring (n =
798, two joints were not available due to finger amputa-
tion). Each NBF feature was scored as absent or present
at each site by both observers. In the case of disagree-
ment, the images were reviewed again and consensus
was reached. Pre-consensus agreement for XR scoring
Figure 1 Examples of the features of new bone formation
(NBF) observed by plain radiography and computed
tomography in patients with gout. A. Spur. B. Osteophyte. C.
Periosteal NBF. D. Ankylosis. E. Sclerosis. Top panel shows plain
radiographic images and lower panel shows CT images. CT,
computed tomography.
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was 93% for spur (kappa 0.58), 74% for osteophyte
(kappa 0.29), 93% for periosteal NBF (kappa 0.15), 99%
for ankylosis (kappa 0.40) and 86% for sclerosis (kappa
0.64). Pre-consensus agreement for CT scoring was 87%
for spur (kappa 0.46), 76% for osteophyte (kappa 0.32),
94% for periosteal NBF (kappa 0.15), 99% for ankylosis
(kappa 0.33) and 86% for sclerosis (kappa 0.69). In addi-
tion, if a spur was present on CT, the spur length was
measured in millimetres (mm) as the distance from the
point at which cortex changes angle to the tip of spur.
In the presence of sclerosis, the relative density was
assessed by measuring the Hounsfield units (HU) at the
site of sclerosis, and at adjacent cortical and trabecular
bone, using the CT workstation software. For spur
length the intraclass correlation coefficient was 0.71
(95% confidence interval (95% CI) 0.67 to 0.74) and for
sclerosis HU was 0.64 (95% CI 0.60 to 0.68).
Statistical analysis
Data were analysed using Prism (v5, GraphPad, San
Diego, CA) and SPPS (v15, SPSS Inc., Chicago, IL).
Mean with standard deviations (SD) and percentages
were used to describe NBF scores. For the site analysis,
joints were grouped into the DIP joints, PIP joints
(including the IP joint of the thumb), MCP joints, carpal
region (base of the first metacarpal, multangular, sca-
phoid, lunate), and radius/ulna. To account for the dif-
ferent number of joints at each site, data were expressed
as the percentage affected/patient. HU at different bone
sites and NBF features at the different joint sites were
analyzed by repeated measures analysis of variance
(ANOVA) with Tukey’s multiple comparison post hoc
test. Radiographic and CT NBF data were analyzed
using unpaired t tests and Fisher’s exact tests. For the
purposes of the site-by-site analysis, each joint was con-
sidered an independent unit for analysis. To address the
possibility that lesions were nested within individuals,
the number of affected joints per patient was also used
in Pearson correlation analysis. All tests were two tailed
and P < 0.05 was considered significant.
Results
Patient characteristics
The clinical and imaging characteristics of the patients
have been reported in detail previously [6,7,14]. There
were 19 (95%) men with mean (SD) age of 56.0 (10.8)
years. The mean (SD) disease duration was 19.5 (12.8)
years and serum urate was 0.49 (0.13) mmol/L. Eleven
(55%) has microscopically proven disease. The majority
of patients (16/20, 80%) had subcutaneous tophi, and
the mean (SD) number of subcutaneous tophi was 30
(56). On plain radiographs of the hands, erosion was
present in 270/798 (33.8%) joints and joint space nar-
rowing in 113/558 (20.3%) scored sites. On plain
radiographs of the hands, the mean (SD) modified S-
vdH erosion score was 37 (39), narrowing score was 17
(22) and combined score was 54 (59). On CT scanning
of the hands, there were 237/798 (29.7%) joints with
erosion and 194/798 (24.3%) joints with intraosseous
tophus. For those joints with bone erosion, the mean
(SD) erosion diameter was 4.8 (3.9) mm. For those joints
with intraosseous tophus, the mean (SD) tophus dia-
meter was 9.6 (7.3) mm.
Features of new bone formation on plain radiographs
and CT scans
The features of NBF observed in the hand radiographs
and CT scans are shown in Table 1. The most frequent
forms of NBF were bone sclerosis and osteophyte. Spur
and periosteal NBF were less common, and ankylosis
was rare. CT detected more spurs and osteophytes than
plain radiography (Table 1). Agreement between plain
radiographs and CT for the features of NBF was 88%
for spur (kappa 0.51), 81% for osteophyte (kappa 0.52),
96% for periosteal NBF (kappa 0.37), 99% for ankylosis
(kappa 0.54) and 90% for sclerosis (kappa 0.75). For
those spurs identified on CT, the mean (SD) spur length
was 4.4 (2.3) mm. For those sites of bone sclerosis iden-
tified on CT, the relative density of sclerosis was inter-
mediate between trabecular and cortical bone; mean
(SD) HU for sclerosis was 814 (288), compared with 180
(86) for adjacent trabecular bone and 1,443 (431) for
cortical bone, ANOVA P < 0.0001 (Figure 2). These
results confirmed the increased density of trabecular
bone at sites of bone sclerosis.
Relationship of new bone formation with other
radiographic features on plain radiography
Site-by-site analysis of the plain radiographs showed that
NBF was strongly associated with bone erosion and joint
space narrowing (Table 2). Those joints with bone ero-
sion were more likely to be affected by all features of
NBF compared with non-eroded joints. Furthermore,
erosion scores were higher in eroded joints that were
affected by NBF. Similarly, joints with joint space nar-
rowing were more likely to be affected by NBF, with
higher narrowing scores in narrowed joints affected by
spur, ankylosis and sclerosis. Overall, the relationship of
osteophyte with erosion and joint space narrowing was
weaker than other forms of NBF.
Relationship of new bone formation with erosion and
tophus on computed tomography: site-by-site analysis
Site-by-site analysis of the CT scans also showed that
joints with bone erosion were more likely to have NBF
than those without erosion (Table 3). On CT scanning,
erosions were larger in eroded joints that were affected
by certain forms of NBF: spur, periosteal NBF and
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sclerosis. Similarly, joints with intraosseous tophus were
more likely to have NBF than those without tophus,
although the relationship between intraosseous tophus
size and NBF was weaker (Table 3). Spur length corre-
lated with both erosion diameter r = 0.67 (0.63 to 0.71)
P < 0.0001 and tophus diameter r = 0.67 (0.63 to 0.71)
P < 0.0001. Tophus density, measured in HU, was not
associated with features of NBF (data not shown).
Relationship of new bone formation with erosion and
tophus on computed tomography: patient level analysis
In the patient level analysis, the number of joints
affected by NBF on CT scanning did not correlate with
gout disease duration or number of attacks in the pre-
ceding six months (data not shown). Serum urate corre-
lated with the number of joints affected by bone spur (r
= 0.54, P = 0.01) and ankylosis (r = 0.54, P = 0.01) on
CT, but not other features of NBF. Similarly, the num-
ber of subcutaneous tophi correlated with the number
of joints affected by bone spur (r = 0.50, P = 0.02) and
ankylosis (r = 0.66, P = 0.001) on CT, but not other fea-
tures of NBF. Consistent with the site-by-site analysis,
the number of joints affected by CT erosion and
intraosseous tophus correlated with the number of joints
affected by bone spur, sclerosis, ankylosis and periosteal
NBF on CT scanning (Table 4). In contrast, there was
no relationship between the number of joints affected
by CT erosion and intraosseous tophus and the number
of joints affected by osteophyte.
Further analysis was undertaken by examining CT
involvement within groups of joints (Table 5). Erosion
was more commonly observed at the radius/ulna site
than at the DIP joints (repeated measures one way
ANOVA P = 0.03, Tukey post hoc test P < 0.05), with no
other differences between other sites. Similarly tophi were
more frequently observed in the PIP joints and radius/
ulna site compared with the DIP joints (repeated mea-
sures one way ANOVA P = 0.01, Tukey post hoc test P
< 0.05 for both). There was no difference between sites
for spurs, osteophytes or ankylosis. The radius/ulna site
was more frequently affected by sclerosis and periosteal
new bone formation compared with other sites (Table 5).
In the patient level analysis, the percentage of joints
affected by spur and sclerosis correlated highly with the
percentage of joints affected by tophus and erosion at
each group of joints (r = 0.62-0.97, P < 0.01 for all).
With the exception of tophus at the PIP joints, the per-
centage of joints affected by periosteal NBF also corre-
lated with the percentage of joints affected by tophus
and erosion at each site (r = 0.50-0.88, P < 0.05 for all).
At the DIP joints and the PIP joints, there was no corre-
lation between the percentage of joints affected by
osteophytes and the percentage of joints affected by ero-
sion or tophus (P > 0.52 for all). However, at the other
joints sites (MCP joints, wrists and radius/ulna site),
there was a modest correlation between percentage of
joints affected by osteophytes and the percentage of
joints affected by erosion (r = 0.47, P < 0.05 for all).
Discussion
This detailed quantitative analysis has demonstrated that
NBF is closely related to other features of joint disease
Table 1 Features of new bone formation (NBF) in patients with gout.
Number of joints with XR
NBF features (number =
798 joints)
Mean (SD) number of joints with
XR NBF features (number = 20
patients)
Number of joints with CT
NBF features (number =
798 joints)
Mean (SD) number of joints with
CT NBF features (number = 20
patients)
Spur 76 (9.5%) 3.8 (5.7) 141 (17.6%) 7.1 (7.9)
Osteophyte 167 (20.9%) 8.4 (6.5) 243 (30.5%) 12.2 (7.7)
Periosteal
NBF
51 (6.4%) 2.6 (3.4) 48 (6.0%) 2.4 (3.4)
Ankylosis 7 (0.9%) 0.35 (1.1) 5 (0.6%) 0.25 (3.4)
Sclerosis 207 (25.9%) 10.4 (8.9) 228 (28.6%) 11.4 (8.3)
CT, computed tomography; SD, standard deviation; XR, plain radiography.
Figure 2 Hounsfield units at sites of sclerosis and adjacent
bone in joints affected by bone sclerosis. ***P < 0.0001 by
Tukey’s post hoc test.
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in gout. The most common features of NBF in gout are
sclerosis, osteophyte and spur. The finding that bone
erosion is strongly associated with all features of NBF
suggests that loss of bone and formation of new bone
may be connected during the joint remodelling process
in joints affected by gout.
Although tophus size was not strongly associated with
features of NBF in this analysis, joints with intraosseous
tophus were more likely to have associated NBF, com-
pared with those joints without tophus. These data sug-
gest that the tophus may play a role in development of
these features, particularly spur, periosteal NBF, ankylo-
sis and sclerosis. The tophus represents a foreign body
granulomatous response to collections of monosodium
urate crystals, involving innate and adaptive immune
cells [17]. It seems unlikely that MSU crystals within





























Spur Present 73 3 64.9 <0.0001 4.2 (1.2) <0.0001 55 14 28.7 <0.0001 2.6 (1.2) <0.0001
Absent 197 525 (20.2-
208.5)
2.2 (1.3) 58 431 (15.0-
54.8)
1.8 (0.9)
Osteophyte Present 139 28 19.0 <0.0001 3.2 (1.5) <0.0001 75 58 13.2 <0.0001 2.2 (1.1) 0.65
Absent 131 500 (12.1-
29.7)





Present 50 1 119.8 <0.0001 3.9 (1.4) <0.0001 29 7 21.6 <0.0001 2.5 (1.1) 0.08
Absent 220 527 (16.4-
872.9)
2.5 (1.5) 84 438 (9.2-
51.0)
2.1 (1.1)
Ankylosis Present 7 0 30.1 0.0005 5.0 (0.0) <0.0001 5 0 45.2 0.0003 4.0 (0.0) <0.0001
Absent 263 528 (1.7-
529.)
2.7 (1.5) 108 445 (2.5-
823.6)
2.1 (1.1)
Sclerosis Present 194 13 101.1 <0.0001 3.2 (1.5) <0.0001 91 62 25.6 <0.0001 2.4 (1.1) <0.0001
Absent 76 515 (54.9-
186.3)
1.5 (0.7) 22 383 (14.9-
43.7)
1.4 (0.7)
Relationship of new bone formation (NBF) with erosion and joint space narrowing (JSN) (n = 798 joints for erosion and 558 joints for JSN). CI, confidence interval;
OR, odds ratio; SD, standard deviation.






























Spur Present 127 14 45.1 <0.0001 7.0 (3.7) <0.0001 121 20 48.4 <0.0001 10.9 (7.9) 0.02
Absent 110 547 (25.0-
81.3)
4.5 (3.0) 73 584 (28.4-
82.4)
8.2 (6.7)
Osteophyte Present 116 127 3.3 <0.0001 5.6 (3.2) 0.27 99 144 3.3 <0.0001 8.4 (5.3) 0.006
Absent 121 434 (2.4-
4.5)





Present 41 7 16.6 <0.0001 7.2 (4.4) 0.0005 38 10 14.5 <0.0001 10.4 (7.9) 0.65
Absent 196 554 (7.3-
37.5)
5.5 (3.3) 156 594 (7.1-
27.0)
9.7 (7.5)
Ankylosis Present 5 0 26.6 0.002 8.3 (3.1) 0.11 5 0 35.1 0.0008 10.7 (7.3) 0.80
Absent 232 561 (1.5-
482.7)
5.8 (3.8) 189 604 (1.9-
638.0)
9.8 (7.6)
Sclerosis Present 179 49 32.3 <0.0001 6.5 (3.8) <0.0001 161 67 39.1 <0.0001 10.4 (7.9) 0.03
Absent 58 512 (21.3-
48.9)
3.9 (2.0) 33 537 (24.9-
61.5)
7.3 (4.6)
Relationship of new bone formation (NBF) with erosion and intraosseous tophus on CT (n = 798 joints). CI, confidence interval; CT, computed tomography; OR,
odds ratio; SD, standard deviation.
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tophi have a direct effect on bone cells to promote NBF,
as these crystals promote osteoclastogenesis and inhibit
osteoblast differentiation, survival and function, resulting
in net bone resorption [18-21]. MSU crystals within the
tophus are surrounded by an inflammatory cell rim (the
corona zone) which, in turn, is surrounded by a fibro-
vascular zone with organized deposition of collagen
[22]. It is conceivable that the processes that contribute
to formation of the fibrovascular zone also contribute to
the development of some forms of NBF, such as bone
sclerosis. In addition to expression of cytokines typically
associated with bone resorption, such as IL-1 and TNF-
a [17,23], transforming growth factor b (TGFb) is also
expressed in the tophus [17]. TGFb has various effects
on bone homeostasis, but may contribute to NBF under
certain conditions [24]. Other pathways implicated in
NBF in other arthropathies such as the bone morphoge-
netic proteins (BMPs) and Wnt signalling pathways have
not been explored to date in patients with gout; activa-
tion of these pathways may also contribute to the pat-
terns of NBF in joints affected by gout [25-27].
Magnetic resonance imaging studies have demon-
strated a close relationship between resolution of
inflammatory bone lesions and development of new
bone formation in ankylosing spondylitis [28,29]. Our
study was not able to address bone inflammation at
sites of NBF, as this feature is not visualized using CT.
The current study has defined the features of NBF that
occur in patients with gout. Longitudinal multimodality
imaging studies are now needed to understand the
mechanisms of NBF in gout, and the impact of treat-
ment on these features.
It is also possible that elevated circulating concentra-
tions of soluble urate contribute to NBF in patients with
gout. Several studies have reported that serum urate
concentrations positively correlate with total body bone
mineral density [30,31]. A large observational study of
older men has demonstrated that higher serum urate
concentrations are associated with lower prevalence of
osteoporosis and osteoporotic fractures [31]. These find-
ings persisted after adjusting for potential confounders
including body mass index, alcohol use, diuretic therapy
and kidney disease. The mechanisms of this relationship
are not fully understood, but analysis of bone turnover
markers showed that serum urate negatively correlated
with urinary NTX-1, a marker of bone resorption [31].
In contrast, there was no relationship observed between
serum urate concentrations and P1NP, a marker of
osteoblast activity. These observations suggest that urate
may have opposing effects on bone, leading to erosion
at local sites in the context of MSU crystals in tophi,
but also maintenance of total bone density in response
to high soluble urate concentrations. It is unknown
whether the mechanisms of local NBF within joints
affected by MSU crystals are the same as those influen-
cing total body bone density. In this analysis, we did
identify a weak relationship between serum urate and
the number of joints affected by bone spur and ankylo-
sis, but not other forms of NBF.
It is well documented that gout is more likely to pre-
sent in joints previously affected by osteoarthritis [32].
Consistent with these observations, osteophytes were
associated with the presence of joint space narrowing,
erosion and intraosseous tophus in the site-by-site
Table 4 Patient level CT analysis.
Spur Osteophyte Periosteal NBF Ankylosis Sclerosis
Number of joints with CT erosion 0.88*** 0.38 0.60** 0.67** 0.90***
Number of joints with CT intraosseous tophus 0.87*** 0.31 0.56* 0.70*** 0.82***
Spearman correlations between number of joints affected by CT new bone formation (NBF) and other imaging features of gout (n = 20 patients). * < 0.05, ** <
0.01, *** < 0.001. CT, computed tomography; n, number.











Spur 12.5 (21.1) 20.0 (22.7) 18.0 (25.5) 16.3 (26.6) 24.8 (32.9)
Osteophyte 23.1 (25.1) 41.0 (23.2) 24.5 (24.2) 33.1 (32.3) 27.5 (30.2)
Periosteal
NBF
1.9 (6.1)*** 6.0 (10.5)* 2.5 (5.5)** 9.4 (16.1) 16.3 (23.3)
Ankylosis 0.0 (0.03) 1.5 (3.7) 0.0 (0.0) 0.6 (2.8) 0.0 (0.0)
Sclerosis 18.1 (23.5)** 35.0 (25.2) 23.5 (25.8)* 30.6 (28.8) 41.3 (33.7)
Erosion 20.9 (22.6)* 35.8 (26.4) 26.5 (29.8) 29.4 (31.5) 41.3 (40.8)
Tophus 21.4 (26.7)* 39.3 (31.2) 34.0 (36.6) 29.4 (32.5) 41.3 (43.9)
aIncludes IP joint of the thumb. *P < 0.05 compared with radius/ulna, **P < 0.01 compared with radius/ulna, ***P < 0.001 compared with radius/ulna. All P refer
to Tukey’s post hoc test. Data are expressed as a mean (standard deviation) percentage of sites per patient to account for the different number of joints at each
site. CT, computed tomography; NBF, new bone formation.
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analysis. However, the relationship of erosion and
intraosseous tophus with osteophyte was much weaker
than with the other forms of NBF. Furthermore, in the
overall patient level analysis, a relationship between
osteophyte and NBF was not observed. The analysis of
different joint areas showing a relationship between ero-
sion and tophus with osteophytes at sites other than the
DIP and PIP joints suggests that these processes may be
related in some circumstances and not in others.
This study shows that erosion, tophus and certain fea-
tures of NBF (periosteal new bone formation and sclero-
sis) are more common at the radius/ulna region
compared with the distal interphalangeal joints. It is
possible this difference may have been due to improved
resolution at the larger site, compared with the small
DIP joints. However, it is more likely that this repre-
sents a real difference. Potential explanations for this
observation are that local factors such as biomechanical
strain at the distal radioulnar region contribute to for-
mation of MSU crystals, or promotion of tophus forma-
tion in the presence of MSU crystals at this site.
Patients in this study had longstanding gout with a
mean disease duration of almost 20 years and high
serum urate levels. Although we did not observe a rela-
tionship between disease duration and NBF features in
the patient level analysis, the results described in this
paper may not necessarily be applied to patients with
early disease or with well controlled disease. Similarly,
this study only included joints of the hands, and it is
possible that NBF changes may occur at different rates
in the feet, which are more frequently affected by gout.
Analysis of the feet is planned in future studies.
A further question that arises from this work is
whether CT is preferable to plain radiography to accu-
rately detect features of NBF. CT was able to detect
more osteophytes and spurs than plain radiography.
However, the inter-reader agreement was similar
between XR and CT, with reasonable agreement
between the methods for detection of the various fea-
tures of NBF, suggesting that plain radiographs may be
sufficient. The additional cost and radiation exposure
from CT further supports plain radiography as the
method of choice.
The strong relationship between bone loss (erosion)
and NBF observed in this cross-sectional study suggests
that NBF features such as sclerosis and spur formation
may be repair phenomena triggered by joint destruction.
At present, it is unclear whether NBF in gout occurs
before bone erosion and tophus formation, develops
concurrently with bone erosion, or occurs as part of tis-
sue remodelling in response to tophus and erosion.
Exploration of the temporal relationship between
tophus, NBF and bone erosion now requires detailed
longitudinal studies. Ideally these will be multimodality
imaging studies which include plain radiography, MRI
and dual energy CT, an advanced imaging method that
allows visualization of urate deposits [33]. Intervention
studies are also needed to address whether effective
urate-lowering therapy can prevent or reverse features
of NBF, and to understand the impact of these changes
on musculoskeletal function. Evaluation of NBF as part
of the imaging assessment in future studies of gout may
clarify the pathogenesis and impact of NBF in this
disease.
Conclusions
This detailed quantitative analysis has demonstrated that
NBF occurs more frequently in joints affected by other
features of gout. This work suggests a connection
between bone loss, tophus, and formation of new bone
during the process of joint remodelling in gout.
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